WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 482
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 692

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 2'039  1'978  1'918  1'859  1'802  1'232  917  604 
Births 81  79  78  76  75  56  43  31 
Surviving infants 77  75  74  73  71  53  40  28 
Pop. less than 5 years 360  352  344  336  327  233  175  118 
Pop. less than 15 years 928  903  880  856  832  567  423  272 
Female 15-49 years 485  470  455  441  427  293  211  143 

Number of reported cases

(Click for retrospective incidence data for Gambia (the))
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  45  71  336  284 
Mumps
ChartChart
 
Pertussis
ChartChart
  157 
Polio*
ChartChart
 
Rubella
ChartChart
  35  66  39 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  44 
Tetanus (total)**
ChartChart
  567 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Gambia (the))
Vaccine year result method % card seen                                                
BCG 2011  99  DHS   90  98  98  96  96  98  97  98  85 
DTP1 2011  98  DHS   90  99  99  98  98  99*  89  98  89 
DTP3 2011  88  DHS   90  95  97  96  98  98  74  92 
DTP4          80  35 
IPV1          95  71 
HepB_BD          98  96  96  95  89 
HepB3 2011  88  DHS   90  95  97  96  97  98  87  93 
Hib3 2011  88  DHS   90  95  97  96  98  98  74 
JapEnc         
MCV1          97  97  96  94  95  92  86  69 
MCV2          79  77  73  53  56 
MenA         
PCV1          99  99  98  98  99 
PCV2          97  98  97  98  99 
PCV3 2011  93  EPI   99  95  97  96  96  98 
Pol3 2011  90  DHS   90  95  96  97  98  98  92  94  53 
Rota1          99  98  96  90 
RotaC          95  97  92  90 
RCV1         
TT2plus 2011  92  EPI   99  85  82  60  78  71  90  73 
PAB          60  58 
VAD1          57  54 
YFV 2011  90  EPI   99  97  97  96  97  95  91 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Gambia (the))
BCG
ChartChart
  98  98  96  98  98  99  98  85 
DTP1
ChartChart
  99  99  98  99  99  97  98  89 
DTP3
ChartChart
  95  97  96  97  98  80  92  63 
HepB3
ChartChart
  95  97  96  97  98  91 
HepB_BD
ChartChart
 
Hib3
ChartChart
  95  97  96  97  98  90 
IPV1
  95  71 
MCV1
ChartChart
  97  97  96  96  95  89  86  69 
MCV2
ChartChart
  79  81  73  53  56 
PCV3
ChartChart
  95  97  96  96  98 
Pol3
ChartChart
  95  96  97  96  98  84  94  53 
RCV1
 
RotaC
ChartChart
  95  97  92 
YFV
ChartChart
  97  97  96  97  95  85 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
HPV 9-13 years; +6 months; No
IPV 4 months; Yes
Measles 9, 18 months; Yes
MR 9, 18 months; Yes From June 2017
OPV birth; 2, 3, 4, 9, 18 months; Yes
Pneumo_conj 2, 3, 4 months; Yes
Rotavirus 2, 3, 4 months; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes 15-49 years
VitaminA 6, 12, 18, 24, 20, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 71  43  29  83  50  67  33 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 28  33  35    31  10   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.